echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Zhejiang pharmaceutical companies enter 10 billion blockbuster varieties!

    Zhejiang pharmaceutical companies enter 10 billion blockbuster varieties!

    • Last Update: 2021-04-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    A few days ago, the official website of the State Food and Drug Administration showed that Zhejiang Lepu Pharmaceutical’s acarbose tablets were submitted for approval in the imitation of 4 types of acarbose tablets.


    According to data, Acarbose tablets are an alpha-glycosidase inhibitor developed by Bayer, which is mainly used in combination with diet control to treat type 2 diabetes and reduce the postprandial blood sugar of people with impaired glucose tolerance.


    Overall sales of acarbose tablets

    Source: Minet database

    According to data from Meinenet, in 2019, the total sales of acarbose tablets in China's urban public hospitals, county-level public hospitals, urban community centers, and township health centers (Chinese public medical institutions) terminals and Chinese urban physical pharmacies terminals totaled nearly 100 100 million yuan.


    Source: MED2.


    In terms of consistency evaluation, acarbose tablets have been reviewed by 7 pharmaceutical companies.


    Source: official website of the State Food and Drug Administration, Mi Nei.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.